雅虎香港 搜尋

搜尋結果

  1. 2024年5月3日 · On Friday, CARsgen Therapeutics Holdings Ltd (2171:HKG) closed at 6.19, 65.95% above the 52 week low of 3.73 set on Jan 31, 2024. Data delayed at least 15 minutes, as of May 03 2024 09:08 BST. All markets data located on FT.com is subject to the FT Terms & Conditions. All content on FT.com is for your general information and use only and is not ...

  2. 2021年6月19日 · View real-time 2171 stock price and news, along with industry-best analysis. Explore Our Brands WSJ ... HK$3.44B Shares Outstanding 575.64M EPS (TTM)-HK$1.49 P/E Ratio (TTM)N/A Dividend Yield N/A ...

  3. SHANGHAI, April 29, 2024 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancie PR Newswire Apr 29 20:50 Analysis HK %Chg ...

  4. 2024年3月28日 · CARsgen Therapeutics Holdings Ltd (2171:HKG) company profile with history, revenue, mergers & acquisitions, peer analysis, institutional shareholders and more. CARsgen Therapeutics Holdings Ltd is a China-based investment holding company principally ...

  5. 2024年4月20日 · View the latest CARsgen Therapeutics Holdings Ltd. (2171) stock price, news, historical charts, analyst ratings and financial ... HK$-1.47 Market Cap HK$ 2.59 B Shares Outstanding 575.64 M Public ...

  6. 科济药业-B (02171) 6.17 %. 简介:科济药业控股有限公司是一家主要从事创新嵌合抗原受体 (CAR)T 细胞疗法发现、开发及销售业务的中国投资控股公司。. 该公司的疗法用於治疗血液恶性肿瘤和实体瘤。. 该公司已开发升级版靶向B细胞成熟抗原 (BCMA)的CAR-T产品CT053 ...